Latest Executive Incentives News

Page 1 of 10
Servcorp Limited delivered a record FY26 with a 24% rise in underlying NPBIT to $87 million, boosted dividends by 14%, and outlined a cautious yet optimistic FY27 growth strategy.
Victor Sage
Victor Sage
20 Aug 2026
Service Stream Limited (ASX: SSM) posted a modest 1.1% revenue rise to $2.35 billion for FY26, driven by Utilities and Asset & Facility Management growth, including a new Defence contract. EBITDA from operations surged 11.8% to $163.4 million, while statutory NPAT dipped 3.8% due to $21.2 million in ERP modernization costs. The company declared a final dividend increase to 3.5 cents per share.
Victor Sage
Victor Sage
19 Aug 2026
Pioneer Credit (ASX:PNC) has delivered a standout FY26 with a 245% surge in net profit after tax to $23.1 million, driven by disciplined debt portfolio investments and refinancing gains. The company sets ambitious targets for FY27-FY29, including a $35 million NPAT goal.
Claire Turing
Claire Turing
19 Aug 2026
NextEd Group navigated a tough international education market in FY26, boosting underlying EBITDA by 7% to $15.3 million even as revenue fell 6.7%. A $13 million goodwill impairment weighed on net losses, but ongoing cost discipline and vocational course growth underpin a resilient platform.
Victor Sage
Victor Sage
19 Aug 2026
Origin Energy reported a 6% increase in FY26 profit to $1.57 billion despite a 10% revenue drop, advancing renewable projects and extending Eraring Power Station operations, while managing a customer data breach.
Maxwell Dee
Maxwell Dee
13 Aug 2026
Percheron Therapeutics announces Dr Michael Baker as incoming CEO, replacing Dr James Garner who steps down after three years. Baker’s appointment aligns executive incentives with shareholder value as the company prepares for a pivotal HMBD-002 clinical trial.
Ada Torres
Ada Torres
10 Aug 2026
Rimfire Pacific Mining has appointed Bronwyn Barnes as Executive Chair and secured $2.3 million in a placement to advance its scandium exploration and development strategy.
Maxwell Dee
Maxwell Dee
7 Aug 2026
Island Pharmaceuticals has marked a major step forward in its antiviral program with the start of GMP manufacturing for Galidesivir, expanded USAMRIID collaboration, and FDA orphan drug designation. Regulatory approvals for compassionate use in Uganda’s Ebola outbreak and a new dose optimisation study with Texas Biomed further de-risk the pathway to approval.
Victor Sage
Victor Sage
30 July 2026
Coronado Global Resources has promoted CFO Barrie van der Merwe to CEO, tasking him with steering the coal miner back to profitability and lowering its debt burden.
Maxwell Dee
Maxwell Dee
14 July 2026
Qoria Limited marked a turning point in FY25, delivering 25% growth in Annual Recurring Revenue and a 684% jump in underlying EBITDA, setting sights on 20% EBITDA margin in FY26 amid global digital safety expansion.
Sophie Babbage
Sophie Babbage
8 July 2026
Osmond Resources is advancing its Orión EU Critical Minerals Project with imminent assay results, upcoming resource estimates, and a secondary listing on the Madrid Stock Exchange, aiming to become the EU's first producer of rare earth-bearing minerals.
Maxwell Dee
Maxwell Dee
3 July 2026
WhiteHawk Limited has appointed Adrian Vallino as Group CEO to spearhead its global expansion and commercialisation of the Quixxi Clarity AI platform, aiming to grow recurring revenue and diversify its distribution channels.
Sophie Babbage
Sophie Babbage
2 July 2026

Browse the archive

Full archive